Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0QG9A
|
||||
| Former ID |
DNCL001912
|
||||
| Drug Name |
Apadenoson
|
||||
| Synonyms |
Stedivaze (TN)
|
||||
| Drug Type |
Small molecular drug
|
||||
| Company |
PGx Health
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C23H30N6O6
|
||||
| InChI |
InChI=1S/C23H30N6O6/c1-3-25-21(32)18-16(30)17(31)22(35-18)29-11-26-15-19(24)27-14(28-20(15)29)6-4-5-12-7-9-13(10-8-12)23(33)34-2/h11-13,16-18,22,30-31H,3,5,7-10H2,1-2H3,(H,25,32)(H2,24,27,28)/t12-,13-,16-,17+,18-,22+/m0/s1
|
||||
| InChIKey |
FLEVIENZILQUKB-XTWQNQIISA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A2a receptor | Target Info | Agonist | [540254] | |
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| References | |||||
| Ref 522811 | ClinicalTrials.gov (NCT00990327) Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI. U.S. National Institutes of Health. | ||||
| Ref 540254 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3290). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.